Malaria Diagnostics Market

Malaria Diagnostics Market Outlook 2031

The global malaria diagnostics market size was USD 786.51 Million in 2022 and is projected to reach USD 1.19 Billion by 2031 expand at a substantial CAGR 4.73% during the forecast period, 2023 – 2031. The growth of the market is attributed to the increasing demand for the malaria diagnosis studies & research, along with the introduction of innovative diagnostic techniques for the treatment and cure for malaria.

Malaria is a life-threatening disease primarily caused by Plasmodium parasites transmitted through mosquitoes. With a series of drug development and expansion of the existing healthcare system, this disease is now curable. Malaria starts off as a febrile illness present in non-immune individuals. The symptoms of this disease normally lasts from ten to fifteen days after the parasite entered into the body through mosquito bite. The initial symptoms are mild headaches, chills, and fever.

Get Free Sample Report

However, once it starts developing in the body, its symptoms changes and may lead to respiratory distress, cerebral malaria, and multi-organ failure if necessary measures are not timely taken up. Accurate and prompt diagnosis is required for the accurate identification and effective treatment of malaria. The initial steps revolve around finding the malaria parasites and antigens present in the patient blood.

Various diagnosis and studies show that there are different forms of malaria parasites depending on the regions of origin. This malaria parasite is widely prevalent in those countries located near the Equator, where the temperature is generally higher than average temperature of many parts of the globe. That is why malaria cases are extensively occurred in countries of Africa and those countries near the Equator. As per the 2017 survey by World Health Organization (WHO), the deaths of 435,000 people were reported due to the lack of proper malaria diagnosis.

Malaria Diagnostics Market Trends, Drivers, Restraints, and Opportunities

• Rising demand for diagnostic solutions for the testing and treatment of malaria due to wide prevalence of the diseases especially in the subtropical and tropical region such as Africa is a key driver for the market.
• Increasing investment from private investors to expand the R&D works to curb the spread of malaria and develop preventive measures are key driving factors for the market.
• The outbreak of COVID-19 pandemic has affected the malaria diagnostics market as there was a sharp decline in the growth of malaria globally. This acts as a key challenge to hamper the market expansion.
• Growing development of the advanced malaria diagnostic methods and technique is anticipated to propel the market expansion.
• Introduction of several programs and initiatives from government agencies from countries such as Democratic Republic of Congo, Peru, India, Uganda, and Columbia are key opportunities for the market expansion.

Scope of The Malaria Diagnostics Market Report

The report on the global malaria diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Global Malaria Diagnostics Market Segment Insights

Microscopy to dominate the global malaria diagnostics market

Based on the technology, the global malaria diagnostics market is divided into microscopy, rapid diagnostic tests, and molecular diagnostic tests. The molecular diagnostic tests are further bifurcated into conventional polymerase chain reaction (PCR) and real-time PCR. The microscopy segment is expected to dominate the market in the coming years owing to wide adoption of the technique for malaria diagnostics.

As per the report by WHO, microscopy was one of the most reliable methods that around 204 million of microscopic malarial diagnosis were adopted around the world. Malarial parasites such as P.malariae, P.vivax, P.ovale, and P.falciparum were all identified and studied through microscopy at five different stages. On the other hand, the molecular diagnostic tests segment is anticipated to exhibit a substantial CAGR during the forecast period 2023-2031.

These tests include both conventional and real-time PCR which are accurate, capable of identifying low parasite count, and highly sensitive. Molecular diagnostic tests were very expensive at the time of introduction but due to constant innovation and improved technology, now researchers and scientists are producing techniques and devices that can help to conduct these tests in a cost efficient way.

Get Free Sample Report

Africa is projected to constitute a major market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Africa is projected to constitute a major market share due to the presence of the largest number of the disease cases. One of the most prominent parasites of malaria found in this region is the P.falciparum, estimating at 99% of all malarial cases in Africa. WHO estimated that 93% of the world malaria deaths and 92% of the world malaria cases were reported to be originated from Africa.

Meanwhile, the market in Asia Pacific is expected to hold a large share of the market in the coming years owing to rising cases of malaria and the region represented the second position for the malaria diagnostics market share. India accounted for a major share in terms of volume in the regional market. The microscopy testing method is widely adopted in India due to its cost-effective nature and accurate results in diagnosis.

Get Free Sample Report

Segments

The global malaria diagnostics market has been segmented in terms of

Technology

• Microscopy
• Rapid Diagnostic Tests
• Molecular Diagnostic Tests
  • Conventional PCR
  • Real-time PCR

Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Access Bio Inc
• Abbott Laboratories
• Premier Medical Corporation Pvt Ltd
• Sysmex Partec GmbH
• bioMerieux; Beckman Coulter Inc
• Siemens Healthineers
• Leica Microsystems GmbH
• Nikon Corporation
• Olympus Corporation
• Bio-Rad Laboratories Inc

Competitive Landscape

Some of the major players in the global malaria diagnostics market are Access Bio Inc; Abbott Laboratories; Premier Medical Corporation Pvt Ltd; Sysmex Partec GmbH; bioMerieux; Beckman Coulter Inc; Siemens Healthineers; Leica Microsystems GmbH; Nikon Corporation; Olympus Corporation; and Bio-Rad Laboratories Inc. Most of these companies account for their market shares because of their strong distribution channel and global presence.